TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1898697

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy (0.2 mg/kg per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperinsulinemic clamp (insulin concentration > 1435 pmol/L)
Number of subjects: 0
Study: 6849746

Group type: COMPARATOR
Intervention: i.v. nicardipine (0.5-20 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral nicardipine (10-40 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 40 mg nicardipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: 20 mg nifedipine
Number of subjects: 10
Study: 31344451

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic cell transplantation (HCT)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Chemo-naivety before HCT
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Acute graft-versus-host disease (aGVHD) grades II to IV
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Serotherapy
Number of subjects: 380

Group type: COMPARATOR
Intervention: Immune profiles of total absolute lymphocytes
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: CD3-CD16+CD56+ natural killer cells, CD3+ T cells, CD3+CD4+ T cell subset, and CD3+CD8+ T cell subset
Number of subjects: 380

Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Increased levels of IgM, IgA, and IgG
Number of subjects: 380
Study: 30859995

Group type: EXPERIMENTAL
Intervention: AR19 (20-mg capsule)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Reference (2 x 10-mg tablets)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: AR19
Number of subjects: 36

Group type: COMPARATOR
Intervention: Reference
Number of subjects: 36
Study: 28490225

Group type: EXPERIMENTAL
Intervention: Short arm plaster cast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long arm plaster cast
Number of subjects: 0
Study: 25183475

Group type: EXPERIMENTAL
Intervention: Web-based decision aid
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: Print-based decision aid
Number of subjects: 1253
Study: 23886675

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 134
Study: 21474638

Group type: EXPERIMENTAL
Intervention: VR-augmented balance training
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Conventional balance training (CB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 42
Study: 17909087

Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg once daily for 6 weeks
Number of subjects: 22
Study: 16836626

Group type: EXPERIMENTAL
Intervention: Sildenafil (n = 279)
Number of subjects: 553

Group type: COMPARATOR
Intervention: Placebo (n = 274)
Number of subjects: 553
Study: 15758248

Group type: EXPERIMENTAL
Intervention: Men with coronary atherosclerosis
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Men with three-vessel coronary artery disease
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Adiponectin plasma level
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (healthy men)
Number of subjects: 67
Study: 10880411

Group type: COMPARATOR
Intervention: Balloon angioplasty/placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stent/placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty/abciximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stent/abciximab
Number of subjects: 0
Study: 8720432

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) infusion at 1, 10, and 100 ng/min/dl forearm volume
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) infusion
Number of subjects: 15
Study: 1633010

Group type: COMPARATOR
Intervention: Total parenteral nutrition (PN)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (PN) plus biosynthetic human growth hormone (bGH) 4 UI/daily
Number of subjects: 38
Study: 6565306

Group type: EXPERIMENTAL
Intervention: Waterbed
Number of subjects: 15

Group type: COMPARATOR
Intervention: Foam
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard mattresses
Number of subjects: 15
Study: 3534588

Group type: EXPERIMENTAL
Intervention: One cycle of CMF chemotherapy (cyclophosphamide, methotrexate, and 5-fluorouracil) preoperatively
Number of subjects: 98

Group type: COMPARATOR
Intervention: Postoperative adjuvant chemotherapy (not specified in detail)
Number of subjects: 98
Study: 31471752

Group type: EXPERIMENTAL
Intervention: Simulation tool for planning and predicting RFA zones
Number of subjects: 45
Study: 29325658

Group type: EXPERIMENTAL
Intervention: Tele-Motivational Interviewing (MI)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Nonusers
Number of subjects: 29
Study: 27695785

Group type: EXPERIMENTAL
Intervention: 4% linseed oil (LO)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 4% linseed oil and 2% malate (LOM)
Number of subjects: 12
Study: 24185690

Group type: EXPERIMENTAL
Intervention: Postoperative functional hand-based splint
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard spica splint
Number of subjects: 30
Study: 22033034

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) chemotherapy with cisplatin/paclitaxel
Number of subjects: 454

Group type: COMPARATOR
Intervention: Intraperitoneal (IP) chemotherapy with carboplatin followed by cisplatin/paclitaxel
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Patients with low pre-chemotherapy CA125 levels
Number of subjects: 454
Study: 20088995

Group type: EXPERIMENTAL
Intervention: Postcard intervention sent centrally at 1, 2, 3, 4, and 5 months after discharge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three trial-specific assessments (baseline, 3- and 6-month assessments)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postcard intervention
Number of subjects: 0
Study: 19039946

Group type: EXPERIMENTAL
Intervention: Impaza (superlow-dose antibodies to endothelial NO synthase)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15717335

Group type: EXPERIMENTAL
Intervention: Telemedicine cognitive intervention (videoconferencing)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Face-to-face cognitive intervention
Number of subjects: 22
Study: 12775314

Group type: EXPERIMENTAL
Intervention: Clobetasone butyrate 0.05% cream
Number of subjects: 3500
Study: 11593504

Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg daily
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 8911885

Group type: EXPERIMENTAL
Intervention: Sodium tiludronate 200 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium tiludronate 400 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium tiludronate 600 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium tiludronate 800 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1874095

Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diazepam (0.3 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Thiopentone (5 mg/kg)
Number of subjects: 6
Study: 6344138

Group type: EXPERIMENTAL
Intervention: Iopamidol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Renografin‐60 (meglumine diatrizoate)
Number of subjects: 40
Study: 31608454

Group type: EXPERIMENTAL
Intervention: Leukoreduced (LR) RBCs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard unmodified (STD) RBCs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leukoreduced and γ‐irradiated (LRγ) RBCs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nontransfused patients
Number of subjects: 0
Study: 28159539

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 25 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Midazolam 1.5 mg
Number of subjects: 200
Study: 27635065

Group type: EXPERIMENTAL
Intervention: Pathology tissue specimens for prostate cancer
Number of subjects: 4340

Group type: EXPERIMENTAL
Intervention: Pathology tissue specimens for lung cancer
Number of subjects: 4340

Group type: EXPERIMENTAL
Intervention: Pathology tissue specimens for colorectal cancer
Number of subjects: 4340

Group type: EXPERIMENTAL
Intervention: Pathology tissue specimens for adenoma
Number of subjects: 4340

Group type: EXPERIMENTAL
Intervention: Pathology tissue specimens for ovarian cancer and borderline tumors
Number of subjects: 4340

Group type: EXPERIMENTAL
Intervention: Pathology tissue specimens for breast cancer
Number of subjects: 4340

Group type: EXPERIMENTAL
Intervention: Pathology tissue specimens for bladder cancer
Number of subjects: 4340
Study: 24993764

Group type: EXPERIMENTAL
Intervention: Ioflupane ((123)I)
Number of subjects: 928
Study: 22159910

Group type: EXPERIMENTAL
Intervention: BNP-32 (3 pmol kg(‐1) min(‐1) intravenously for 4 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: BNP-32
Number of subjects: 10
Study: 20565296

Group type: EXPERIMENTAL
Intervention: Seasonal influenza vaccine
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo (vitamin B injections)
Number of subjects: 118
Study: 17656607

Group type: EXPERIMENTAL
Intervention: Triage liaison physician (TLP) shifts
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control shifts
Number of subjects: 14
Study: 16274597

Group type: EXPERIMENTAL
Intervention: Automated injector (Softinject)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional syringe
Number of subjects: 300
Study: 11766999

Group type: EXPERIMENTAL
Intervention: Paroxetine (20-40 mg/day)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Amitriptyline (75-150 mg/day)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 179

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 179
Study: 9159676

Group type: EXPERIMENTAL
Intervention: Clear corneal incision
Number of subjects: 100

Group type: COMPARATOR
Intervention: Scleral tunnel incision
Number of subjects: 100
Study: 7934151

Group type: EXPERIMENTAL
Intervention: Terbutaline via Turbuhaler (1.0 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Terbutaline via Turbuhaler (2.5 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Terbutaline via CFC inhaler (1.0 mg without Nebuhaler)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Terbutaline via CFC inhaler (2.5 mg with Nebuhaler)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3073868

Group type: EXPERIMENTAL
Intervention: Interferon (Wellferon) at doses of 5 MU/m2 i.m. daily for the first 4 weeks and three times weekly for 5 months thereafter
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Interferon (Wellferon)
Number of subjects: 70
Study: 30553700

Group type: EXPERIMENTAL
Intervention: Oral administration of RG7800
Number of subjects: 0
Study: 27650320

Group type: EXPERIMENTAL
Intervention: Home-but not Alone mobile health application educational programme
Number of subjects: 118

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 118
Study: 25154701

Group type: EXPERIMENTAL
Intervention: BodyPump™ training (PUMP)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 68
Study: 23891224

Group type: EXPERIMENTAL
Intervention: cobas® 4800 assay
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: m2000 real-time™ assay
Number of subjects: 921
Study: 21114770

Group type: EXPERIMENTAL
Intervention: Bupropion-SR 150 mg/day for 2 months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (19 healthy men)
Number of subjects: 19
Study: 19646565

Group type: COMPARATOR
Intervention: Emergency contraception (recent use)
Number of subjects: 718

Group type: COMPARATOR
Intervention: Emergency contraception (ever having used)
Number of subjects: 718
Study: 16462011

Group type: EXPERIMENTAL
Intervention: SampEn
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: SpecEn
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (age-matched)
Number of subjects: 11
Study: 14625752

Group type: EXPERIMENTAL
Intervention: Laparoscopic GBP
Number of subjects: 58

Group type: COMPARATOR
Intervention: Open GBP
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 11406908

Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 580

Group type: COMPARATOR
Intervention: Control
Number of subjects: 580
Study: 9133884

Group type: EXPERIMENTAL
Intervention: Contact with a stroke family care worker
Number of subjects: 417

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 417
Study: 7700071

Group type: EXPERIMENTAL
Intervention: Cilazapril (2.5-5 mg, once daily for 12 weeks)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Nitrendipine (10-20 mg, once daily for 12 weeks)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Cilazapril
Number of subjects: 114

Group type: COMPARATOR
Intervention: Nitrendipine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Cilazapril and Nitrendipine
Number of subjects: 114
Study: 3428344

Group type: EXPERIMENTAL
Intervention: Lofepramine (140 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amitriptyline (50 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31853543

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML)
Number of subjects: 1912

Group type: COMPARATOR
Intervention: ASCVD-risk and CAC measures
Number of subjects: 1912

Group type: COMPARATOR
Intervention: Systolic blood pressure and cholesterol
Number of subjects: 1912
Study: 30075596

Group type: EXPERIMENTAL
Intervention: Electrophysiological study (ES) positive, treated by catheter ablation and/or device implants
Number of subjects: 72

Group type: COMPARATOR
Intervention: Electrophysiological study (ES) negative, no interventional treatment
Number of subjects: 72
Study: 27206810

Group type: EXPERIMENTAL
Intervention: Hydralazine/isosorbide dinitrate (HYIS) 50 mg/20 mg t.i.d. for 24 weeks
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Hydralazine/isosorbide dinitrate (HYIS)
Number of subjects: 147
Study: 25782469

Group type: EXPERIMENTAL
Intervention: 2.25 g SMO.IR and placebo alcohol preparation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2.25 g SMO.IR and alcohol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2.25 g SMO.IR matching placebo and alcohol
Number of subjects: 24

Group type: COMPARATOR
Intervention: 2.25 g SMO.IR matching placebo and placebo alcohol preparation
Number of subjects: 24
Study: 23453866

Group type: EXPERIMENTAL
Intervention: AGE-S (250 mg aged garlic extract, 100 μg vitamin B12, 300 μg folic acid, 12.5 mg vitamin B6, 100 mg L-arginine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 22053315

Group type: EXPERIMENTAL
Intervention: Weight Watchers
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Slimming World
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Rosemary Conley
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Group based, dietetics led programme
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: General practice one to one counselling
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Pharmacy led one to one counselling
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Choice of any of the six programmes
Number of subjects: 740

Group type: COMPARATOR
Intervention: Comparator group (minimal intervention control)
Number of subjects: 740
Study: 19640315

Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone injections
Number of subjects: 70

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 70
Study: 17432284

Group type: EXPERIMENTAL
Intervention: Psicoeducative Program
Number of subjects: 177
Study: 15152882

Group type: EXPERIMENTAL
Intervention: 50-minute telephone counseling with 2 follow-up calls
Number of subjects: 632

Group type: COMPARATOR
Intervention: Print only control (pamphlet/booklet)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: 2 calls
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: 6 calls
Number of subjects: 632
Study: 11321635

Group type: EXPERIMENTAL
Intervention: Induced mood via auditory, visual, and imaginal channels
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Self-reports of induced mood
Number of subjects: 118
Study: 8583171

Group type: EXPERIMENTAL
Intervention: BROM II device for measuring lumbar mobility
Number of subjects: 47
Study: 2526031

Group type: EXPERIMENTAL
Intervention: Danazol (200 mg three times a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-dose medroxyprogesterone acetate (100 mg a day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Danazol and high-dose MPA
Number of subjects: 20
Study: 925164

Group type: EXPERIMENTAL
Intervention: Rational State Directed Imagery (RSDI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rational (cognitive) restructuring treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 0
Study: 31101403

Group type: EXPERIMENTAL
Intervention: Bexagliflozin, 20mg, daily for 24 weeks
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 28276521

Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unsaturated fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SFA with fish oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 26045359

Group type: EXPERIMENTAL
Intervention: Stribild(®) (EVG/COBI/FTC/TDF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: NNRTI with FTC/TDF (control group)
Number of subjects: 0
Study: 25139785

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 22422736

Group type: EXPERIMENTAL
Intervention: 3-drug chemotherapy (including doxorubicin) with or without lung radiation
Number of subjects: 417

Group type: COMPARATOR
Intervention: 2-drug chemotherapy (dactinomycin and vincristine)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: CT-only nodules with lung radiation
Number of subjects: 417

Group type: COMPARATOR
Intervention: CT-only nodules without lung radiation
Number of subjects: 417
Study: 18603457

Group type: EXPERIMENTAL
Intervention: Cannabinoid (delta‐9‐tetrahydrocannabinol (THC) and cannabidiol mixture) as an oromucosal spray
Number of subjects: 18
Study: 17931519

Group type: EXPERIMENTAL
Intervention: 3-port laparoscopic cholecystectomy
Number of subjects: 75

Group type: COMPARATOR
Intervention: 4-port laparoscopic cholecystectomy
Number of subjects: 75
Study: 16299295

Group type: EXPERIMENTAL
Intervention: MSP3-LSP vaccine with Montanide ISA 720
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MSP3-LSP vaccine with aluminum hydroxide
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MSP3-LSP vaccine
Number of subjects: 35
Study: 12435326

Group type: EXPERIMENTAL
Intervention: Pharmacological therapies for OA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cochrane systematic reviews of OA therapies
Number of subjects: 0
Study: 9790423

Group type: EXPERIMENTAL
Intervention: Benznidazole at a dose of 5 mg/kg/day for 60 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benznidazole
Number of subjects: 0
Study: 8828629

Group type: EXPERIMENTAL
Intervention: Supplementation with marine oils
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supplementation with blackcurrant oils
Number of subjects: 0

Group type: COMPARATOR
Intervention: Good compliance with dietary regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control population
Number of subjects: 0
Study: 1924079

Group type: EXPERIMENTAL
Intervention: Dobutamine (4 micrograms/kg/min)
Number of subjects: 5
Study: 7199836

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg of morphine epidurally
Number of subjects: 174

Group type: COMPARATOR
Intervention: 0.1 mg/kg of morphine intramuscularly
Number of subjects: 174

Group type: COMPARATOR
Intervention: saline epidurally
Number of subjects: 174
Study: 30717684

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate injection
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sclerotherapy
Number of subjects: 113
Study: 28651804

Group type: EXPERIMENTAL
Intervention: Trabectedin 1.5mg/m2 by 24‐hour IV infusion
Number of subjects: 232

Group type: COMPARATOR
Intervention: Dacarbazine 1g/m2 by 20‐120‐minute IV infusion once every three weeks
Number of subjects: 232
Study: 27523954

Group type: COMPARATOR
Intervention: Target temperature management (TTM) at 36°C
Number of subjects: 163

Group type: COMPARATOR
Intervention: Target temperature management (TTM) at 33°C
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Thrombomodulin at 24h
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Thrombomodulin at 48h
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: IL-6 baseline levels
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Thrombomodulin increase from baseline to 48h
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Thrombomodulin increase from baseline to 72h
Number of subjects: 163
Study: 25015203

Group type: EXPERIMENTAL
Intervention: Brachytherapy boost (10 Gy in 2 fractions)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Long-course preoperative CRT (50.4 Gy in 28 fractions, per oral tegafur-uracil and L-leucovorin)
Number of subjects: 224
Study: 20865425

Group type: EXPERIMENTAL
Intervention: Short intense local exercise (single‐legged toe lifting)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Euglycemic hyperinsulinemic clamp
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Before exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: After exercise
Number of subjects: 18
Study: 19280592

Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-Tyr3-octreotide (TOC)
Number of subjects: 24
Study: 17572574

Group type: EXPERIMENTAL
Intervention: Surgical drainage on one side of the face
Number of subjects: 50

Group type: COMPARATOR
Intervention: No surgical drainage (control side)
Number of subjects: 50
Study: 15142211

Group type: EXPERIMENTAL
Intervention: Dentifrice A (RDA=85, REA=3.4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dentifrice B (RDA=189, REA=2.0)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dentifrice C (RDA=132, REA=42.7)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between dentifrice C and dentifrices A and B
Number of subjects: 0